Skip to main content

Table 1 Results

From: Subthreshold yellow laser for fovea-involving diabetic macular edema in a series of patients with good vision: effectiveness and safety of a fovea-sparing technique

Patient

Eye

DM

OCT

PreL CRT

PostL CRT (12 week)

Last PostL CRT

Decrease in CRT

Power (mW)

Spots

Follow up (months)

Changes on AF

PreL VA

PostL VA

1

RE

II

IRC

288

257

250

38

450

350

18

NO

20/22

20/22

1

LE

II

IRC

280

265

263

17

450

460

10

NO

20/22

20/22

2

LE

I

IRC

296

284

277

19

325

80

15

NO

20/22

20/20

3

RE

I

IRC, NSD

302

283

276

26

350

150

9

NO

20/20

20/20

4

RE

II

IRC

303

268

247

56

350

200

10

NO

20/22

20/22

5

RE

I

IRC, IRE

301

288

295

6

400

60

12

NO

20/25

20/22

5

LE

I

IRC

287

272

251

36

300

180

9

NO

20/32

20/32

6

RE

II

IRC

269

274

254

15

350

200

14

NO

20/28

20/28

7

LE

II

IRC, IRE

275

267

270

5

500

180

15

YES

20/28

20/25

8

RE

II

IRC

258

226

240

18

400

200

15

NO

20/28

20/25

8

LE

II

IRC, IRE

243

230

230

13

500

180

17

YES

20/32

20/25

9

LE

II

IRC, IRE

270

260

260

10

450

250

13

NO

20/32

20/25

10

RE

I

IRC

376

350

323

53

300

480

9

NO

20/20

20/20

10

LE

I

IRC, NSD

510

431

442

68

300

560

9

NO

20/20

20/20

11

RE

II

IRC, IRE

355

393

393

−38

400

380

6

NO

20/32

20/25

12

RE

II

IRC

335

333

332

3

382

350

9

NO

20/28

20/28

13

LE

II

IRC, IRE

254

226

226

28

325

300

7

NO

20/22

20/22

14

RE

II

IRC, IRE

324

320

322

2

300

400

7

NO

20/22

20/22

15

LE

II

IRC

341

295

293

48

425

160

12

NO

20/32

20/25

16

LE

II

NSD

288

256

234

54

450

450

12

NO

20/25

20/20

17

LE

II

IRC, IRE

282

266

252

30

350

400

9

NO

20/20

20/20

18

RE

II

IRC, IRE

259

250

242

17

350

300

9

NO

20/20

20/20

19

LE

II

IRE

226

226

226

0

700

350

9

NO

20/28

20/28

  1. DM Diabetis Mellitus, PreL Pre Laser, PostL Post Laser, CRT Central retinal thickness, AF Autofluorescence, VA Visual acuity, IRC Intraretinal cysts, NSD Neurosensory detachment, IRE Intraretinal exudates